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ABSTRACT
Collagen structure has been shown to influence tumor cell invasion, metastasis 
and clinical outcome in breast cancer. However, it remains unclear how it affects other 
solid cancers. Here we utilized multi-photon laser scanning microscopy and Second 
Harmonic Generation to identify alterations to collagen fiber structure within the 
tumor stroma of head & neck, esophageal and colorectal cancers. Image segmentation 
algorithms were then applied to quantitatively characterize these morphological 
changes, showing that elongated collagen fibers significantly correlated with poor 
clinical outcome (Log Rank p < 0.05). We used TGF-β treatment to model fibroblast 
conversion to smooth muscle actin SMA-positive cancer associated fibroblasts (CAFs) 
and found that these cells induce the formation of elongated collagen fibers in vivo. 
However, proteomic/transcriptomic analysis of SMA-positive CAFs cultured ex-vivo 
showed significant heterogeneity in the expression of genes with collagen fibril 
organizing gene ontology. Notably, stratifying patients according to stromal SMA-
positivity and collagen fiber elongation was found to provide a highly significant 
correlation with poor survival in all 3 cancer types (Log Rank p ≤ 0.003). In summary, 
we show that increased collagen fiber length correlates with poor patient survival in 
multiple tumor types and that only a sub-set of SMA-positive CAFs can mediate the 
formation of this collagen structure.
INTRODUCTION
The observation that the extracellular matrix ECM 
associated with solid tumors is significantly altered 
compared to normal tissues dates back to Dvorak’s seminal 
description of solid tumors as ‘wounds that do not heal’ [1]. 
However, it is only in recent years, with technical advances 
in imaging and 3D cell culture techniques, that we are 
beginning to appreciate the effect of ECM composition 
and architecture on tumor cell behavior.  For example, 
the increased tissue tension that develops as a result of 
desmoplasia around solid tumors causes the activation 
of signaling pathways involved in mechanotransduction, 
leading to increased of tumor cells [2]. Elevated interstitial 
pressure has also been shown to play a role in blunting the 
efficient delivery of chemotherapeutics to tumors [3]. 
Fibrillar collagen is the principal structural 
component of the ECM surrounding solid tumors, and 
it has been demonstrated that collagen cross-linking 
by lysyl-oxidase (LOX) enzymes promotes tumor cell 
invasion, stromal activation and desmoplasia [2, 4, 5]. 
The morphology of collagen fibers can be analyzed 
in histological samples using multi-photon laser 
scanning microscopy (MPLSM) and Second Harmonic 
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Generation (SHG), exploiting the non-centrosymmetric 
properties of fibrillar collagen to generate highly specific 
non-linear optical signals and enable the visualization 
of intrinsic tissue contrast [6, 7]. This has shown that 
structural changes to collagen fibers, such as alterations 
in orientation relative to the tumor boundary, can facilitate 
tumor cell invasion [8, 9]. Furthermore, detection of 
these changes in tumor specimens have been found to 
significantly correlate with poor prognosis in human breast 
cancer patients [6].
Most research into the role of collagen topology in 
tumor progression has been performed in breast cancer, 
and few studies have investigated collagen morphology 
in other tumor types. It is also unclear how structural 
alterations to fibrillar collagens are regulated. The stromal 
presence of cancer associated fibroblasts (CAFs) with a 
myofibroblast phenotype significantly correlates with poor 
survival rates in multiple tumor types and these cells have 
been shown to regulate a number of tumor promoting 
functions [8, 10, 11]. Myofibroblasts are contractile cells 
that express α-smooth muscle actin (SMA) and secrete 
ECM proteins, playing a critical role in tissue remodeling 
and fibrosis/desmoplasia [12, 13]. While many studies 
have investigated the secretory role of myofibroblasts 
with regard to cytokines and growth factors (such 
as IL- 6, HGF and SDF-1) [10, 11, 14, 15], the role of 
these cells in regulating ECM structure within the tumor 
microenvironment remains poorly understood.
In this study we use MPLSM and SHG with 
image segmentation algorithms to quantitatively analyze 
collagen structure in head & neck squamous cell 
carcinoma (HNSCC), esophageal adenocarcinoma (EAC) 
and colorectal adenocarcinoma (CRC). We show that 
tumors with elongated collagen fibers have significantly 
poor survival outcome and that formation of this altered 
collagen structure can be regulated by TGF-β-induced, 
SMA-positive myofibroblastic CAFs. Notably however, 
proteomic/transcriptomic analysis of SMA-positive 
CAFs cultured ex-vivo shows significant heterogeneity 
in the expression of genes associated with collagen 
fibril organization, and survival analysis reveals tumors 
containing SMA-positive CAFs that create elongated 
collagen fibers have a particularly poor prognosis.
RESULTS
Collagen fibril organizing gene (CFOG) 
expression distinguishes between normal and 
tumor tissues
To investigate whether the expression of genes 
associated with collagen structure was altered in solid 
tumors, we used publicly available databases for HNSCC, 
EAC and CRC (TCGA RNASeq). The expression of genes 
within the collagen fibril organization gene ontology term 
(GO: 0030199; CFOGs) were analyzed in normal and 
tumor samples, and unsupervised hierarchical clustering 
showed that the expression of these genes clearly 
distinguished between normal and tumor samples in the 
majority of cases (Figure 1A–1C).
Notably, comparative marker selection analysis identified 
a number of common genes significantly up-regulated in 
all cancer types (BH adj. p < 0.05; Figure 1D). The proteins 
encoded by these genes play a critical role in each step of the 
production and maturation of fibrillar collagens: enzymes 
regulating lysine and proline hydroxylation (PLOD3, LEPRE1); 
cross-linking of collagen fibers (LOXL2); and the predominant 
fibrillar collagen found in tumor stroma (COL1A1).
These data suggest that alterations in the production 
and organization of fibrillar collagens is an important 
event in the progression of HNSCC, EAC and CRC.
SHG imaging reveals structural changes to 
stromal collagen in tumor tissues
Since the expression of a number of CFOGs 
were found to be up-regulated in the HNSCC, EAC 
and CRC tissues, we used SHG to image alterations in 
fibrillar collagen morphology in normal and malignant 
human tissues. In normal tissue, varying degrees of SHG 
signal were detected in different regions of the mucosa 
and submucosa (Figure 2A–2B). In areas of squamous 
epithelium and muscle, relatively low levels of SHG 
signal was detected; whereas in sub-epithelial stromal 
regions a strong SHG signal was detected, identifying 
abundant fibrillar collagen, which consisted of short, 
‘curly’ and randomly orientated fibers. Notably, in a subset 
of tumor cases, a clearly altered collagen stromal structure 
was observed where collagen fibers were elongated and 
organized in parallel (Figure 2C). However, not all tumors 
contained this alteration in collagen morphology, nor was 
it observed in normal tissues, despite the abundance of 
fibrillar collagen.
Quantification of collagen fiber length and 
alignment
We then quantitatively analyzed collagen structure 
based on SHG images as described previously [16]. 
Accurate segmentation of collagen fibers was achieved 
using a curvelet-denoising filter (CT) [17] followed by an 
automated tracking algorithm (CT-FIRE) [16] to isolate 
individual fibers (Figure 3A). 
CT segmentation of SHG images was used to 
analyze the orientation of collagen fibers within a given 
image by calculating the vector sum of absolute fiber 
angles, termed the alignment coefficient (Figure 3B). 
CT-FIRE segmentation was used to measure individual 
fiber lengths: this showed that in all cases the majority 
of collagen fibers were relatively small; however a 
number of elongated fibers were found in tumor samples 
(Figure 3C). This morphological change was therefore 
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Figure 1: The expression of genes associated with Collagen Fibril Organization Gene (CFOG) ontology (GO:0030199) 
differentiates between tumor and normal tissue in Head & Neck Squamous cell carcinoma (HNSCC), Esophageal 
Adenocarcinoma (EAC) and Colon Adenocarcinoma (COAD). RNA Sequencing data from the Cancer Genome Atlas was used 
to analyze matched tumor and normal samples. (A–C) Unsupervised Hierarchical clustering, using a Euclidean distance measure of pairwise 
average-linkage to determine sample clusters. Expression levels were row normalized for visualization and sample type is shown above the 
heat map (Yellow = Normal, Red = Tumor). (D) Venn Diagram showing the number of these genes significantly up-regulated between tumor 
and normal tissue (BH adj. p < 0.05) and lists summarizing the genes that are commonly up-regulated in different tumor types. 
Oncotarget4www.impactjournals.com/oncotarget
most appropriately described by analysis of the variance 
in fiber length; and the standard deviation (σ) was used 
as a rudimentary measure of this change in collagen 
morphology.
In order to validate the effectiveness of these 
quantitative metrics at identifying regions where collagen 
fibers were visibly altered, we compared each quantitative 
metric with subjective (qualitative) assessment of 
collagen morphology in images from a single tissue 
microarray (TMA; 162 cores). Each quantitative measure 
was significantly up-regulated (p < 0.0001) in cases 
subjectively identified as having a modified stroma (with 
Figure 2: Aligned and elongated collagen fibers are found in the tumor microenvironment. Representative images of collagen 
fiber morphology in normal squamous epithelium/sub-epithelial stroma (A) and sub-mucosal tissue (B) from esophageal tissue samples. 
(C) Representative image of aligned and elongated collagen fibers in esophageal adenocarcinoma (EAC) tissue, micrographs are shown 
from hematoxylin & eosin (H & E) stained sections imaged using multi-photon laser scanning microscopy (MPLSM): unfiltered 890 nm 
multi-photon excitation (MPE); and 445 nm filtered image collecting second harmonic generation (SHG) signal only (fibrillar collagen). 
Scale Bars represent 100 μm. Corresponding low magnification images are shown in Figure S1.
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aligned and elongated collagen fibers) (Figure 3D); and the 
quantitative metrics were found to be significant classifiers 
of this phenotype using receiver-operating characteristic 
(ROC) analysis (p < 0.0001) (Figure 3E). This shows that 
the objective quantitative measures, accurately identify the 
modified collagen phenotype observed by eye. 
Increased collagen fiber length significantly 
correlates with poor survival rates
We next examined the relationship between collagen 
structure and prognosis using TMAs generated from cohorts 
of HNSCC and EAC patients (n = 213 and 146 respectively 
[18, 19]; Supplementary Table 1). Representative stromal 
regions were imaged from multiple tumor cores and the mean 
value for each patient was used for survival analysis. This 
showed that patients with increased collagen fiber length had 
significantly poorer rates of cancer-specific survival and a 
two-fold increased risk of dying from disease (Figure 4A– 4B; 
HNSCC Log-rank p = 0.008, HR = 2.172 [95% CIs: 1.208 
to 3.907]; and EAC Log Rank p = 0.027, HR = 1.748 [95% 
CIs: 1.059 to 2.885]); whereas increased fiber alignment did 
not significantly predict for patient survival (Figure 4C– 4D). 
Multivariate analysis (correcting for tumor stage and grade) 
showed that fiber length was an independent prognostic factor 
in HNSCC (HNSCC: HR = 2.137, 95% CI [1.15–3.97], adj. 
p = 0.016) but not EAC (HR = 1.178, 95% CI [0.68–2.06], 
adj. p = 0.564) (Figure S2).
To investigate the correlation of collagen fiber 
length with patient survival further, a fully automated 
procedure was employed to analyze a CRC patient 
cohort with stage I/II disease (n = 64), where patients 
had received uniform treatment and either developed 
metastases within 5 years (n = 32) or remained metastasis 
free (n = 32; described previously in Bullock et. al 
[20]). Automated slide scanning and image stitching 
was employed to image the entire TMA, each tumor 
core was then split into 7 regions of interest ROIs 
(Figure 5A–5B) and each ROI was analyzed using the 
image segmentation algorithms described above. The 
maximum value for collagen fiber length or alignment 
within each core was determined and, as above, the mean 
value for each patient was used for survival analysis. 
This automated method was compared to the ‘snapshot’ 
imaging approach employed with the HNSCC and EAC 
TMAs and a highly significant correlation was observed 
(r = 0.837, p < 0.0001, r2 = 0.7014; Figure 5C–5D). As 
with the other tumor types this showed that patients 
with increased collagen fiber length had significantly 
poorer rates of cancer-specific survival with a two-fold 
increased risk of dying (Figure 5E; Log-rank p = 0.034, 
HR = 2.282 (95% CIs [1.040 to 5.007])). This analysis 
also showed that increased fiber alignment indicated 
poor patient survival to a level approaching significance 
(Figure 5F; Log-rank p = 0.067). Similar to HNSCC, 
multivariate analysis showed that fiber length was an 
independent prognostic variable (stage and grade adjusted) 
in CRC (HR = 3.226, 95% CI [1.27–8.18], adj. p = 0.014). 
Myofibroblasts/CAFs regulate collagen 
morphology within the tumor microenvironment
It has been shown previously that CAFs with a 
myofibroblastic (SMA-positive) phenotype promote 
tumor progression and that their presence correlates with 
poor survival rates in multiple tumor types [18, 21, 22]. 
A key function of myofibroblasts in normal physiology 
is to secrete and manipulate ECM proteins as part of the 
wound healing process [12]. Therefore, we investigated 
the role of myofibroblasts/CAFs in regulating intratumoral 
collagen morphology. Immunohistochemical IHC staining 
of tumors for the myofibroblast marker SMA showed clear 
co-localization of positive cells with elongated collagen 
fibers (Figure 6A), suggesting that these cells may regulate 
collagen fiber elongation. To examine this, we used an 
in vivo HNSCC xenograft (5PT cell line) model where 
tumor cells were implanted with myofibroblasts or control 
fibroblasts. Myofibroblasts were generated by treating 
fibroblasts (HFFF2) in vitro with human recombinant 
TGF-β1 for 72 hours, and transdifferentiation confirmed 
by increased SMA/cytoplasmic actin stress fiber 
formation; cellular contractility; up-regulation of fibrillar 
collagens and LOXL2 expression (Figure 6B–6E). 
5PT cells were either injected alone or in 
combination with control fibroblasts or myofibroblasts and 
after 5-weeks the tumors were collected. The persistence 
of HFFF2 over time in this xenograft model was 
confirmed using PCR for human vimentin (hVIM); hVIM 
was not detected in murine fibroblasts (C2TF) or xenograft 
tumors where HFFF2s had not been co-injected with 
tumor cells (Figure S4A). Additionally, the development 
of a myofibroblastic stroma in tumors containing TGF-β 
treated HFFF2s was confirmed by IHC staining for SMA 
(Figure S4B–S4C). Collagen morphology within these 
tumors was then analyzed using SHG imaging. This 
showed that in tumors implanted with myofibroblasts, 
there were significant increases in collagen fiber length 
and alignment compared with tumors co-injected with 
control or no fibroblasts (Figure 6F–6H).
The SMA-positive CAF population is heterogenic 
for the expression of proteins associated with 
collagen fibril organization
Our previous studies using these patient cohorts 
showed that moderate/high stromal SMA expression 
predicted for poor survival in each tumor type [10, 18], 
and analysis of the TMAs constructed for SHG analysis 
produced similar results (Figure 7E–7G). Our observations 
that elongated fibers co-localized with SMA-positive 
cells in human tumors, suggested that collagen fiber 
length could be used as a surrogate marker for an 
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SMA-positive stroma. However, further analysis showed 
that intriguingly, increased collagen fiber length was 
observed in only a sub-set of SMA-positive cases 
(75%, 57% and 40% in HNSCC, OAC and CRC 
respectively; Supplementary Table 2). These percentages 
did not significantly alter when the degree of SMA 
positivity was subdivided into moderate and high groups, 
indicating that the development of elongated fibers 
is not simply a reflection of myofibroblast numbers. 
This suggests a degree of heterogeneity within the 
Figure 3: Automated segmentation and quantification of collagen fiber length and alignment can identify the modified 
collagen stroma observed in tumor tissue. (A) Image segmentation, SHG images from normal esophageal tissue and EAC are used 
to identify collagen fibers using curvelet transformation (CT) and fiber extraction (FIRE) algorithms. Reconstructed images are shown 
for each SHG image. Scale bars represent 100 μm. (B) Histograms showing the distribution of absolute fiber angle in each SHG image, 
measured following CT image segmentation, the alignment co-efficient is also shown for each image. (C) Dot plot showing the length 
of each individual fiber within each SHG image measured using FIRE segmentation; error bars represent the mean ± SD. The standard 
deviation (σ) of fiber length is shown above each panel. (D–E) SHG images of stromal regions from 162 cores of an esophageal cancer tissue 
microarray were qualitatively assessed for modified collagen morphology (1 = cores without evidence of aligned and elongated collagen 
fibers; 2 = cores with evidence of aligned and elongated collagen fibers). Histograms show the mean ± SEM for measures of fiber length 
(σ) (D) and alignment co-efficient (E), statistical significance between groups is assessed by 2-tailed homoscedastic t-test ****p < 0.0001. 
(E) ROC curves showing the sensitivity and specificity for each metric to classify SHG images based on qualitative assessment.
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Figure 4: Increased collagen fiber length but not alignment correlates with poor survival rates in HNSCC and EAC. 
(A–D) Kaplan Meier (KM) plots showing cancer specific survival rates with tables showing the number of patients at risk at 0, 2, 4 and 6 
years are shown below. Quantitative measures of collagen fiber morphology were used to stratify patients showing that increased collagen 
fiber length correlates with significantly poorer survival rates (Log-rank p < 0.05). Multivariate survival analysis is shown in Figure S2.
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Figure 5: Fully automated measurement of collagen fiber morphology shows increased length correlates with poor 
prognosis. (A) Example of stitched SHG images from an entire tumor core with and without evidence of collagen fiber deposition and 
elongation. Scale Bar represents 100 μm. (B) Depiction of automated segmentation of cores into ROIs for analysis and quantification. 
(C–D) Linear regression analysis comparing TMA core quantification using single ‘snapshot’ images of stromal regions or automated 
segmentation (as described in (B)): a CRC TMA (n = 29 patients) was analyzed using both methods and compared. (E-F) Kaplan Meier 
(KM) plots showing cancer specific survival rates with tables showing the number of patients at risk at 0, 2, 4 and 6 years. Quantitative 
measures (using the automated segmentation method) of collagen fiber morphology were used to stratify patients, showing that patients 
with increased collagen fiber length have significantly poorer survival rates (Log-rank p < 0.05). Multivariate survival analysis is shown 
in Figure S2.
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Figure 6: Myofibroblasts/CAFs generate aligned and elongated collagen fibers in vivo. (A) HNSCC and EAC tissue stained 
for α-SMA to denote myofibroblasts/CAFs and serial H & E stained sections imaged for SHG. Scale bar represents 100 μm. (B–D) 
Treating human fetal foreskin fibroblasts (HFFF2) with TGF-β (2 ng/ml for 72 hours) induces fibroblast-to-myofibroblast differentiation. 
(B) Micrographs showing phalloidin staining of filamentous actin and immunocytochemistry staining for α-SMA. (C) Collagen gel 
contraction assay: above, representative image of collagen gels with control or TGF-β treated fibroblasts embedded; below, histogram 
showing gel area measurements from 3 independent experiments, data is presented as mean ± SEM. (D) qPCR measurement of mRNA 
expression in TGF-β treated fibroblasts, presented as mean ± SEM from 3 independent experiments. (E–F) Analysis of 5PT xenograft 
tumors in RAG1−/− mice co-injected with fibroblasts treated as indicated. (E) Micrographs showing representative MPLSM and SHG 
imaging of each condition. (F) Quantification of collagen fiber morphology in xenograft tumors. Data is shown as the mean ± SEM from 
5 tumors per condition. In all cases statistical significance was assessed by 2-tailed homoscedastic t-test (*p < 0.05, **p < 0.01, ***p < 
0.001). Scale bars represent 100 μm. Low Magnification images to supplement panel A and F are shown in Figures S3 and S4 respectively.
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SMA- positive myofibroblast population, where the ability 
to generate elongated collagen fibers is limited to a sub-set 
of cells. 
To examine collagen-forming heterogeneity 
within the myofibroblastic CAF population we used 
multidimensional liquid chromatography and ultra-high 
resolution FT-MS proteomic analysis to analyze the 
ex- vivo expression of collagen fibril organizing proteins 
in normal esophageal fibroblasts (NOFs) compared with 
CAFs isolated from EAC that strongly expressed stromal 
SMA (Figure 7A). CAFs were found to maintain a 
myofibroblast phenotype in culture: shown by significantly 
increased SMA protein expression (p = 0.03; Figure S6A); 
and the formation of SMA positive stress fibers in > 70% 
of cells (Figure S5B). Unsupervised hierarchical clustering 
showed that the proteins formed two discrete clusters: 
cluster 1 (comprising of GREM1, COL14A1, CYP1B1, 
DDR2, LUM, TGFBR2, MIA3 & LOXL2) and cluster 2 
(comprising of COL1A1, COL1A2, COL3A1, P4HA1, 
LOX, LEPRE1, ANXA2, TNXB, PLOD3 & SERPINH1). 
NOFs formed a tight cluster with relatively uniform 
expression, predominantly up-regulating the proteins in 
cluster 1 with downregulation of cluster 2.  In contrast the 
CAFs’ expression profile was significantly heterogenic, 
particularly for expression of proteins in cluster 2, which 
includes the genes up-regulated in EAC compared to 
normal tissues from the TCGA data (Figure 1: COL1A1, 
LEPRE1, PLOD3, SERPINH1 & ANXA2). For example, 
CAF1807 had particularly high expression of each of 
these proteins; whereas CAF 506 clustered separately 
from the other CAF samples and down-regulated the 
expression of each of these proteins (Figure 7B). Similar 
heterogeneity was found in mRNA expression in public 
datasets analyzing the gene expression profiles of CAFs 
from HNSCC and CRC (Figure S5C).
To determine whether the heterogeneous expression 
of these proteins in vitro correlated with the variation in 
collagen fiber elongation observed in SMA positive tumors 
in vivo, we performed SHG imaging of the tumors from 
which CAF1807 and 506 had been extracted. This showed 
that the CAF1807 tumors had significantly (p = 0.0016) 
elongated collagen fibers compared to the CAF 506 
tumors, corresponding with the elevated expression of 
CFOGs from cluster 2 (Figure 7C–7D).
Combined analysis of CAF’s and collagen 
morphology provides refined prognostication
To determine whether the sub-set of SMA-positive 
CAFs with the ability to modify collagen structure 
impacted on patient prognosis we repeated the survival 
analysis by sub-dividing patients with an SMA positive 
tumor stroma according to the presence or absence 
of elongated collagen fibers. In each tumor type this 
significantly refined patient stratification (Figure 7E–7G; 
Log Rank p < 0.003).
DISCUSSION
Our data illustrates the importance of myofibroblasts/
CAF’s role in manipulating the ECM architecture within 
the tumor microenvironment. We show that the formation 
of elongated collagen fibers within the tumor stroma 
predicts for poor patient survival rates in HNSCC, EAC 
and CRC. Furthermore, our data show that the formation 
of this collagen structure is regulated by a sub-set of 
SMA- positive CAFs, highlighting that the SMA-positive 
CAF phenotype is functionally heterogeneous.
There is limited research into the role and effect 
of CAFs on collagen re-modeling within the tumor 
microenvironment. In vitro studies have shown that stromal 
cells isolated from both breast and pancreatic tumors 
can create increasingly aligned fibronectin matrices in 
a syndecan-1 or FAP-dependent manner respectively, 
which facilitate tumor cell motility [23, 24]. Additionally, 
a breast cancer model system has shown that fibroblasts 
over-expressing LOX increase tumor cell invasiveness 
in vivo, by increasing matrix stiffening and focal adhesion 
formation [2]. It is likely that the cross-linking effects of 
LOX enzymes are involved in the formation of elongated 
collagen fibers observed in this study, as LOXL2 was 
one of the genes identified to be up-regulated in HNSCC, 
CRC and EAC (Figure 1D). Indeed, similar structural 
changes were observed in the study analyzing the effect of 
LOX enzyme expression in fibroblasts, on collagen structure 
[2]. Furthermore, our data has shown that LOXL2 was up-
regulated in the TGF-β1 treated fibroblasts that regulate 
elongated collagen fiber formation in vivo (Figure 6E). A 
recent study using an orthotopic non-small cell lung cancer 
model has shown that stromal expression of integrin a11β1 is 
critical for CAF differentiation and collagen reorganization 
in vivo, and this significantly affects metastatic potential [25].
The altered collagen morphology identified in this 
study is likely to be important in controlling tumor cell 
invasion and motility. Collagen structure has been shown 
to be prognostic in breast cancer [6], and a number of 
studies have shown that aligned matrices can affect the 
track-dependent migration of cancer cells [8, 9, 24, 26]. 
Increased expression of type I collagen and related genes is 
also frequently observed in the gene expression signatures 
associated with increased risk of metastasis [27, 28]. 
Cancer cell invasion through a 3D matrix is complex: 
requiring the generation of a tractive force between the 
cell and ECM [21], which is affected by matrix stiffness 
and proteolytic activity [29]. Notably, linearized fibers are 
stiffer than those with a less structured morphology and the 
resulting increased ECM stiffness can significantly promote 
cell migration [2, 29, 30], activating integrin-dependent 
mechanotransduction signaling pathways [31]. Furthermore, 
collagen remodeling has been shown to be associated with 
local cancer cell invasion, and intravital multi-photon 
microscopy has demonstrated that tumor cells migrate rapidly 
along collagen fibers in collagen-rich regions [9, 32–34]. 
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It has also been suggested that collagen can act as 
a physical barrier to the invasion of cells through tissues 
[35], and the activity of proteolytic enzymes such as matrix 
metalloproteinases (MMPs) is critical for tumor invasion 
to occur [36–38]. In comparison the amoeboid nature of 
T-cell movement and their limited expression of MMPs 
is thought to prevent these cells from migrating through 
dense ECM [39, 40]. Therefore, alterations to the ECM 
may have a variable effect on different cell populations’ 
motility within the tumor microenvironment, dependent 
on their method of movement, resulting in enhanced 
cancer cell invasion but limiting immune surveillance by 
preventing T-cell trafficking to the tumor [41].
In summary, recent studies have highlighted 
heterogeneity within the CAF population [42–46]. Our 
study reveals significant heterogeneity even within 
Figure 7: CAFs exhibit significant heterogeneity in the ability to manipulate collagen structure, critically determining 
patient survival rates. (A) SMA IHC images showing the tumors from which CAFs were extracted for further analysis. Scale bars 
represent 100 μm. (B) LC-MS analysis of adult esophageal normal and CAFs (NOF (yellow) and CAF (red) respectively). Unsupervised 
hierarchical clustering, using a Euclidean distance measure of pairwise average-linkage, based on protein expression of genes with collagen 
fibril organization gene ontology (CFOGs). Expression levels are row normalized for visualization. All proteins were identified with 99% 
confidence. (C) Representative images of SHG imaging in the tumors from which CAF 1807 and 506 were extracted. (D) Graphs showing 
the difference in relative expression of each CFOG within cluster 2 and collagen fiber length (mean ± SEM from 6 stromal ROIs in each 
tumor) between CAF 506 and 1807, statistical significance was assessed by 2-tailed homoscedastic t-test **p < 0.01.(E–G) Kaplan Meier 
(KM) plots showing cancer specific survival rates in patients stratified dependent on stromal α-SMA expression (Myofibroblasts/CAFs), 
measured by immunohistochemistry (IHC) and collagen fiber elongation. See also Figure S5.
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the SMA-positive ‘myofibroblastic’ CAF population, 
particularly related to collagen remodeling. The 
prognostic significance across tumor types of an SMA-
positive stroma with elongated collagen fibers reveals 
a sub-set of CAFs associated with aggressive disease, 
and suggests that combined evaluation of collagen 
structure and stromal SMA expression may be highly 
relevant for the pathological and prognostic assessment 
of cancer [47, 48]. 
MATERIALS AND METHODS
Patient tissues
Tissue microarrays (TMAs) were constructed from 
previously described cohorts of HNSCC, EAC and CRC 
patients [18–20] from archival paraffin-embedded material 
at University Hospital Southampton (UHS), using randomly 
selected, 1 mm cores (Alphelys MiniCore 3). All tissue 
collection and storage was handled by a HTA (Human 
tissue authority) licensed tissue bank, with ethical approval 
and informed consent obtained (Rec No. 10/H0504/32 & 
09/H0504/66). Baseline clinicopathological features and 
treatment details are shown in Supplementary Table 1.
SHG Imaging and prognostic correlation testing
Fibrillar collagen was imaged using a custom-built 
multi-photon laser scanning microscope at the Laboratory 
for Optical and Computational Instrumentation (LOCI) 
University of Wisconsin-Madison. A Ti-sapphire (Spectra 
Physics Mai Tai) laser tuned to 890 nm was focused onto 
the sample using a 20x air immersion objective (Nikon 
S Fluor, N.A. = 0.75). Backscattered SHG signal was 
isolated using a 445–20 band-pass filter (Semrock). 
All images were acquired using WiscScan, an image 
acquisition software package developed by LOCI (http://
loci.wisc.edu/software/wiscscan).
Collagen fiber analysis from SHG images was 
performed using CurveAlign (http://loci.wisc.edu/
software/curvealign) and CtFIRE (http://loci.wisc.edu/
software/ctfire), software packages designed at LOCI, 
as described previously [16]. 512 × 512 pixel images 
(457 μm2 area) were analyzed using each program. 
For collagen fiber angle measurements CurveAlign 
analysis was performed using default parameters. For 
measurements of collagen fiber length CtFIRE analysis 
was carried out using slight modifications to the default 
parameters to allow optimal image segmentation: a 
pixel intensity threshold of 25 was implemented to omit 
background noise; and the percentile of remaining curvelet 
coefficients was set to 0.3.
For human tissue analysis Hematoxylin & Eosin 
(H & E) or SMA IHC stained TMAs were used to 
collect SHG images (20X magnification). For the TMAs 
constructed from HNSCC and EAC cohorts a representative 
457 μm2 SHG field of view was collected from stromal 
regions within each tumor core (3–6 tumor cores per 
patient) and analyzed. For the CRC TMA, large SHG fields 
of view were collected on the multiphoton using tiling 
acquisition features built into the WiscScan acquisition 
system and then loaded into FIJI  for stitching [22, 49]. 
Imaging was carried out blinded to clinical outcome. 
The maximal Youden’s index (Sensitivity + 
Specificity −1) for classifying patients with short survival 
rates (cancer specific survival < 3 years) was used as a cut-
off value for categorical survival analysis.
Cell culture
Human fetal foreskin fibroblasts (HFFF2s) were 
obtained from the European Collection of Cell Cultures 
(ECACC; http://www.phe-culturecollections.org.uk) and 
cultured in Dulbecco’s modified eagle medium (DMEM) 
supplemented with 2 mM L-Glutamine and 10% (v/v) 
fetal bovine serum (FBS) at 5% CO2. 
Adult primary fibroblasts were isolated from normal 
and EAC tissues (as described previously [18]) and 
cultured in Dulbecco’s modified eagle medium (DMEM) 
supplemented with 2 mM L-Glutamine and 10% (v/v) 
fetal bovine serum (FBS) at 10% CO2. The fibroblastic 
phenotype was characterized by Western blotting to 
confirm vimentin expression and the absence of pan-
cytokeratin/CD31 expression. The source of each NOF and 
CAF is denoted by a numeric label identifying the patient 
these cells were extracted from and clinicopathological 
details of the tumors that the CAFs were extracted from 
can be found in Supplementary Table 3. 
5PT squamous cancer cells (a cisplatin resistant 
clone derived from the UM-SCC-5 parental cell line (20), 
were kindly provided by Prof Ian C. Mackenzie (Barts and 
the London School of Medicine and Dentistry, UK)). 
Cells were cultured in Dulbecco’s modified eagle 
medium (DMEM) supplemented with 2 mM L-Glutamine 
and 10% (v/v) fetal bovine serum (FBS). Treatment with 
2 ng/ml of human recombinant TGF-β (R & D Systems) 
for 72 hours was used to induce HFFF2 myofibroblast 
differentiation. All cell lines were routinely tested for 
mycoplasma contamination.
Fluorescence microscopy
1 × 104 fibroblasts were plated on permanox chamber 
slides (8 chambers/slide; Thermo Scientific) in serum-free 
DMEM. Cells were fixed (4% w/v PFA), permeabilised 
(PBS + Triton-X100 (v/v 0.5%) and immunofluorescence 
for SMA (Sigma) performed  using an Alexa 564-conjugated 
anti-mouse secondary antibody (Invitrogen) Nuclei and actin 
filaments were visualized using DAPI (1 μg/ml; Molecular 
Probes) and Phalloidin-FITC (0.5 µg/ml; SIGMA) 
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respectively. Images were taken using an Olympus IX81 
fluorescence microscope with a 20X air immersion objective 
(Olympus UPFLN, N.A. = 0.5).
Gel contraction
2 × 105 HFFF2 fibroblasts were mixed with 
10X DMEM (+ 440 mM sodium bicarbonate); sterile 
H2O; and collagen, type 1, rat tail (Millipore) to form a 
1 mg/ml collagen gel (1 ml total volume) [18]. Gels were 
imaged after 24 hours. The degree of gel contraction was 
quantified by measuring gel area (using FIJI [22]).
qPCR
RNA was extracted using the RNeasy kit (Qiagen) 
and reverse transcribed using the RevertAid First 
Strand cDNA Synthesis Kit with oligodT primers, as 
per manufacturer’s instructions. PCR was performed 
using 10 ng of cDNA, 2X SYBR green mastermix 
(Applied Biosytems) and primers (described below) 
under the following conditions: 95°C hold step for 
10 minutes, followed by 40 cycles of 95–60°C for 
15 seconds and 5 minutes respectively. Relative levels 
of mRNA expression were determined using the ddCt 
method. Primer sequences used were as follows: 
ACTB (forward TGGCACCCAGCACAATGAA, 
reverse CTAAGTCATAGTCCGCCTAGAAGCA) as a 
housekeeping gene; COL1A1 (forward ACGAAGAC 
ATCCCACCAATCACCT, reverse AGARCACGTCATC 
GCACAACACCT); COL3A1 (forward AATCAGGTAGA 
CCCGGACGA, reverse TTCGTCCATCGAAGCC 
TCTG); GAPDH (forward AGCAATGCCTCCTGCACCA 
CCAAC, reverse CCGGAGGGGCCATCCACAGTCT); 
VIM (human not mouse; forward GGACCAGCTAA 
CCAACGACA, reverse GCAGCTCCTGGATTTCCTCT).
Xenograft model
All experiments were reviewed and approved by 
both the Science Review Group and the Animal Welfare 
and Ethical Review Board, University of Southampton, 
and were carried out under UK Home Office license 
number PPL30/3028. Animals were obtained from Charles 
River Laboratories; they were bred and housed in a local 
animal facility and used between 8–12 weeks of age. 
1 × 106 5PT ± 3 × 106 HFFF2s were suspended in 
150 ml of DMEM + 2 mM L-Glutamine. 100 ml of this 
mix was injected subcutaneously (s.c.) into the flank of 
partially immunocompromised C57BL/6 RAG1−/− male 
mice. Animals were euthanized after 5 weeks. Tumors 
were removed and fixed in 10% formalin, processed to 
paraffin and H & E stained. Three independent stromal 
regions per tumor were imaged by SHG and analyzed 
using CurveAlign and ctFIRE as described above.
Immunohistochemistry
Automated immunostaining of TMAs was 
performed in the UHS Clinical Cellular Pathology 
Laboratory (anti-SMA antibody; M0851, Dako). 
Staining was evaluated using a semi-quantitative scoring 
system, as described previously [10], according to the 
extent of stromal positivity (low/negative [< 5% stroma 
positive], moderate [patchy/focal expression, 5–50% 
stroma positive] or high [diffuse expression throughout 
tumor, > 50% stroma positive]. Scoring was carried 
out independently by (GJT & TJU) blinded to clinical 
outcome.
Gene expression profiling analysis
Gene expression profiling data was from the 
following publicly available databases was used in 
this study. Figure 1: RSEM normalized results from 
RNASeq data for Patient Matched normal and tumor 
tissues (HNSCC, EAC and CRC TCGA). Figure S5C: 
RMA normalized data from affymetrix array profiling 
of CAFs isolated from HNSCC (GSE38517) and CRC 
(GSE46824). The data was Log transformed (unless 
this had already been carried out prior to upload in 
the databank) and genes within the collagen fibril 
organization gene ontology term (GO:0030199) were 
extracted, using the maximal value where multiple 
probes identified the same gene. Gene pattern software 
was used for downstream analyses [50]. Hierarchical 
clustering was carried out with sample distance measured 
using a Euclidean distance measure and gene distance 
by Pearson’s correlation [51]. Differential expression 
was assessed between normal and tumor samples using 
comparative marker selection [52].
Proteomics
Specimens were homogenized in 200 µL 
of dissolution buffer (0.5 M TEAB, 0.05% SDS) 
using the FastPrep system (Savant Bio, France) and 
pulsed probe sonication. Lysates were centrifuged 
(16, 000 g, 10 min, 40C) and supernatants measured for 
protein content (BCA assay; Thermo Pierce, Rockford, IL, 
USA). A total of 100 mg final protein content from each 
specimen was subjected to reduction, alkylation, trypsin 
proteolysis and 8-plex iTRAQ labeling with the following 
reporter ion / sample ID assignment: 113/NOF-EN102; 
114/NOF2009; 115/NOF-EN251; 116/ CAF1807; 117/
NOF1807; 118/CAF0801; 119/CAF255; 121/CAF506. 
The labelled peptide mixtures were pooled and offline 
separated with high-pH reverse phase (RP) linear gradient 
chromatography using the Waters, XBridge C8 column 
(150 × 3.0 mm, 3.5 mm particle) with the UltiMate 
nano-HPLC system generating a total of 30 fractions 
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(Dionex, Sunnyvale, CA, USA) [53]. Each fraction 
was analyzed using LC-MS with low-pH RP capillary 
chromatography (PepMap C18, 50 μm ID x 50 cm L, 100 
Å pore, 3.5 μm particle) and nanospray ionization FT-MS 
(Dionex Ultimate 3000 UHPLC system - LTQ-Velos Pro 
Orbitrap Elite, Thermo Scientific, USA) [53, 54].
Unprocessed raw files were submitted to Proteome 
Discoverer 1.4 for target decoy searching with SequestHT 
for tryptic peptides, allowing two missed cleavages, 
a tolerance of 10 ppm, a minimum peptide length of 5, 
and a maximum of 2 variable (1 equal) modifications for: 
oxidation (M), deamidation (N, Q), or phosphorylation 
(S,T). Fixed modifications included: Methythio (C) and 
iTRAQ (K, Y, and N-terminus). Fragment ion mass 
tolerances of 0.02 Da for the FT-acquired HCD spectra 
and 0.5 Da for the IT-acquired CID spectra. FDR was 
estimated with the Percolator and set to ≤ 0.01 and 
validation was based on q value at < 0.01. Reporter ions 
were extracted with a tolerance of 20 ppm and were 
omitted if any channels were absent. Quantification 
ratios were median-normalized and transformed to the 
log2 scale. Spectra were searched against the UniProtKB 
TREMBL mouse proteome (Dec 2013).
Statistical analysis
Statistical analysis of patient survival rates was 
carried out using SPSS v22 (IBM SPSS Inc., Chicago, 
IL, USA). The primary endpoint was death from cancer, 
survival time was measured from the date of diagnosis 
in the HNSCC cohort and date of surgery in the EAC 
and CRC cohorts. Other causes of death were censored 
at the time of death. Kaplan-Meier plots (with Log-rank 
[Mantel-Cox] tests) and unadjusted Cox proportional 
hazards models were used to describe the risk of dying from 
cancer within the indicated stratification metrics, unless 
otherwise stated.
Statistical testing between groups and treatment 
conditions was carried out using unpaired 2-tailed 
homoscedastic T-tests, as described in relevant figure legends. 
*p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001.
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